{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-070603","form_type":"8-K","ticker":"SANA","cik":"0001770121","company_name":"Sana Biotechnology, Inc.","filed_at":"2024-06-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.986864+00:00","generated_at":"2026-06-01T05:38:33.083697+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Sana Biotechnology shareholders elect all three Class III directors and ratify EY as auditor","bullets":["Joshua H. Bilenker, M.D. elected with ~149M votes for, ~16M withheld.","Richard Mulligan, Ph.D. elected with ~149.6M votes for, ~14.9M withheld.","Mary Agnes (Maggie) Wilderotter elected with ~144.2M votes for, ~20.3M withheld.","Ratification of Ernst & Young LLP as independent auditor for FY2024 passed with ~178.5M for, ~65K against.","Annual meeting held June 6, 2024; all proposals approved as recommended."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-070603","json":"https://secwatch.observer/filing/0000950170-24-070603.json","markdown":"https://secwatch.observer/filing/0000950170-24-070603.md","text":"https://secwatch.observer/filing/0000950170-24-070603.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770121/000095017024070603/0000950170-24-070603-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770121/000095017024070603/sana-20240606.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:38:33.083697+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}